Comparison of Glucagon-Like Peptide-1 Receptor Agonists and Thiazolidinediones on Treating Nonalcoholic Fatty Liver Disease: A Network Meta-Analysis
In a meta-analysis of 17 randomized trials comparing GLP-1RA (exenatide, liraglutide, albiglutide, taspoglutide, lixisenatide) with placebo or an active comparator in patients with T2DM, patients treated with GLP-1RA experienced more nausea, diarrhea, and weight loss when compared to placebo or patients on active comparator (32)
With a dedicated team of specialists, we utilize the latest inmedical advancements to ensure that your journey is not just about losing weightbut gaining confidence and vitality
B., Kumar, D., Deepti A., Nair, A., Greet, V., An-Katrien, V., Mieke, V